Hematology

Filters1 filter applied

Status

Corrected
No notice
From publisher notices and Retraction Watch. Not checked means nobody has looked yet.

Year

Readable here

Study type

Licence

CC BY

90 papers2 Corrected 86 with full text Questions on this topic

Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms
Jahangir Abdi, Guoan Chen, Hong Chang · Oncotarget · 2013 · Review
Full textCC BY
Shared and distinct mechanisms of iron acquisition by bacterial and fungal pathogens of humans
Mélissa Caza, James W. Kronstad · Frontiers in Cellular and Infection Microbiology · 2013 · Review
Full textCC BY
Establishment of Immortalized Human Erythroid Progenitor Cell Lines Able to Produce Enucleated Red Blood Cells
Ryo Kurita, Noriko Suda, Kazuhiro Sudo et al. · PLoS ONE · 2013
Full textCC BY
A Review for Solitary Plasmacytoma of Bone and Extramedullary Plasmacytoma
Sevil Kilciksiz, Omur Karakoyun-Celik, Fulya Yaman Agaoglu et al. · The Scientific World Journal · 2012 · Review
Full textCC BY
Mechanisms of Resistance to Decitabine in the Myelodysplastic Syndrome
Taichun Qin, Ryan Castoro, Samih El Ahdab et al. · PLoS ONE · 2011
Full textCC BY
Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias
Julien Rocquain, Nadine Carbuccia, Virginie Trouplin et al. · BMC Cancer · 2010
Full textCC BY
Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure
Colin A Hutchison, Tim Plant, Mark Drayson et al. · BMC Nephrology · 2008
Full textCC BY
The Differentiation and Stress Response Factor XBP-1 Drives Multiple Myeloma Pathogenesis
Daniel R. Carrasco, Kumar Sukhdeo, Marina Protopopova et al. · Cancer Cell · 2007
Full textCC BY
Interleukin-1β induced vascular permeability is dependent on induction of endothelial Tissue Factor (TF) activity
Markus Puhlmann, David M Weinreich, Jeffrey M Farma et al. · Journal of Translational Medicine · 2005
Full textCC BY
Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy
J A Glaspy, J S Jadeja, G Justice et al. · British Journal of Cancer · 2002 · Randomised trial
Full textCC BY